UK +44 (0) 203 929 0534 | US +1 (917) 297-6587

Portfolio & Pipeline Strategy

What do our competitors see as the future of breast and gynaecological cancers, and where do we fit in?

Our client, a global biopharmaceutical company with a deep legacy in breast cancer, faces increasingly aggressive and innovative competition to their legacy and future in the OBGyn space.

We holistically reviewed the franchise-level strategies of key competitors, including pipelines, partnering, operations and communications, to establish their individual visions for the future of the space in the short/mid/long term, and the level of threat to our client.

< Previous Case Study

Next Case Study >

Home                  Expertise                   Our Team                   Join us                    Contact us

Brand & Website design by GeoMedia           Privacy Policy

© 2019 Eradigm Limited, Registered England & Wales, No. 10491826
New Derwent House, 69-73 Theobalds Road, London, WC1X 8TA

Home                  Expertise                   Our Team                   Join Us                    Contact Us

Home                  Expertise                   Our Team
Join Us                    Contact Us

© 2019 Eradigm Limited, Registered England & Wales, No. 10491826
New Derwent House, 69-73 Theobalds Road, London, WC1X 8TA

© 2019 Eradigm Limited, Registered England & Wales, No. 10491826
New Derwent House, 69-73 Theobalds Road, London, WC1X 8TA

Brand & Website design by GeoMedia          Privacy Policy